Aduhelm Family Videos

The Food and Drug Administration’s (FDA) approval of the the drug Aduhelm (Aducanumab) for Alzheimer’s treatment though it has not been clinically proven to work and will cost $56,000 a year. In response to this approval, family members have made videos explaining why they don’t want Aduhelm for their loved ones. Watch their stories below.

Justin's Story

Olivia's Story

Bella's Story

Lila's Story